Polymorph compositions, methods of making, and uses thereof
US8821944B1 · kind B1 · utility
1Cited by
10References
21Claims
0Family size
Inventors
Key dates
| Filing date | Jul 16, 2013 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Jul 16, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The described invention provides a biodegradable, biocompatible delivery system of flowable sustained release microparticulate composition of a substantially pure crystalline form of a bioactive agent such as, for example, nimodipine, a process of preparing a therapeutic form of a substantially pure crystalline form of the bioactive agent and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.